Delaware Intellectual Property Cases

Patent - Abbreviated New Drug Application Cases, Dockets and Filings
Cases filed
Cases 1 - 10 of 1,134
ViiV Healthcare Company et al v. Hetero USA, Inc. et al
as 1:2024cv00547
Plaintiff: ViiV Healthcare Company, Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant: Hetero USA, Inc., Hetero Labs Limited Unit-III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mitsubishi Tanabe Pharma Corporation v. Apotex Inc. et al
as 1:2024cv00549
Plaintiff: Mitsubishi Tanabe Pharma Corporation
Defendant: Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Merck Sharp & Dohme LLC. v. Azurity Pharmaceuticals, Inc.
as 1:2024cv00545
Plaintiff: Merck Sharp & Dohme LLC.
Defendant: Azurity Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB et al v. Laurus Labs Limited et al
as 1:2024cv00459
Plaintiff: AstraZeneca AB and AstraZeneca Pharmaceuticals LP
Defendant: Laurus Labs Limited and Laurus Generics Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vertex Pharmaceuticals Incorporated v. Lupin Limited et al
as 1:2024cv00458
Plaintiff: Vertex Pharmaceuticals Incorporated
Defendant: Lupin Limited and Lupin Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Chiesi Farmaceutici S.p.A. et al v. Teva Pharmaceuticals Inc. et al
as 1:2024cv00441
Plaintiff: Chiesi Farmaceutici S.p.A. and Amryt Endo, Inc.
Defendant: Teva Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Actelion Pharmaceuticals Ltd. v. Gland Pharma Limited
as 1:2024cv00434
Plaintiff: Actelion Pharmaceuticals Ltd.
Defendant: Gland Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Horizon Therapeutics U.S. Holding LLC et al v. Teva Pharmaceuticals, Inc.
as 1:2024cv00432
Plaintiff: Horizon Therapeutics U.S. Holding LLC and Horizon Therapeutics USA, Inc.
Defendant: Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals Inc. et al
as 1:2024cv00428
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Teva Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
UroGen Pharma Ltd. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2024cv00417
Plaintiff: UroGen Pharma Ltd. and UroGen Pharma Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?